Indoco Remedies Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹467.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1.71 per cent from ₹475.61 crore. This corresponds to a year-on-year *(YoY) growth of 6.33 per cent.
Operating Profit
Operating Profit stands at ₹41.02 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 17.48 per cent from ₹49.71 crore. This corresponds to a year-on-year *(YoY) growth of 134.00 per cent.
PBDT
PBDT stands at ₹112.25 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1,398.66 per cent from ₹7.49 crore. This corresponds to a year-on-year *(YoY) growth of 1,712.79 per cent.
Profit Before Tax
Profit Before Tax stands at ₹77.72 crore, reflecting a quarter-on-quarter *(QoQ) increase of 410.88 per cent from ₹-25.00 crore. This corresponds to a year-on-year *(YoY) growth of 312.00 per cent.
Net Profit
Net Profit stands at ₹65.44 crore, reflecting a quarter-on-quarter *(QoQ) increase of 376.35 per cent from ₹-23.68 crore. This represents a 280.03 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Indoco Remedies Ltd Earnings
- YOY
- QOQ
Indoco Remedies Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Indoco Remedies Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Indoco Remedies Ltd Financial Reports
Indoco Remedies Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Indoco Remedies | -1.75% | -8.19% | -6.01% | -12.30% | 8.36% | -23.10% |
| Venus Remedies | -0.35% | -8.64% | 4.79% | -10.80% | 56.26% | 259.59% |
| Syncom Formul. | -0.77% | -0.69% | 24.49% | 65.57% | 72.63% | 38.70% |
| Panacea Biotec | 0.06% | -4.82% | -8.02% | -36.05% | 4.58% | -21.29% |
| Windlas Biotech | 0.22% | -8.23% | -13.48% | 11.49% | 16.87% | 4.33% |
| Hester Bios | 2.72% | -4.13% | -3.25% | -17.14% | 44.60% | 23.58% |
| NGL Fine Chem | -1.40% | -6.94% | 12.57% | -8.76% | 28.67% | 92.24% |
Company Info
Company Information
Chairman & Non Executive Dir. : Suresh G Kare
ED / MD / Promoter : Aditi Kare Panandikar
Joint MD & Executive Director : Sundeep V Bambolkar
Independent Non Exe. Director : Satish Shenoy
Independent Non Exe. Director : Ajay Mulgaokar
Independent Non Exe. Director : Vasudha V Kamat
Independent Non Exe. Director : Abhijit Y Gore
CS / Compliance Officer / Legal Head : RAMANATHAN HARIHARAN